FindTrial
Sign In

High-dose chemotherapy

DRUG5 trials

Sponsors

Ohio State University Comprehensive Cancer Center, Universitätsklinikum Hamburg-Eppendorf, University of Oklahoma, Massachusetts General Hospital, Burnasyan Federal Medical Biophysical Center

Conditions

Brain and Central Nervous System TumorsCNS LymphomaLeukemiaMetastatic Breast CancerMyeloablative Chemotherapy Induced Bone Marrow AplasiaNeutropenic EnterocolitisNon-Hodgkin's Lymphoma

Phase 1

Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
TerminatedNCT00124644
Ohio State University Comprehensive Cancer CenterLeukemia
Start: 2006-03-31End: 2008-01-31Target: 30Updated: 2013-05-03
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
NCT02145923
Burnasyan Federal Medical Biophysical CenterMyeloablative Chemotherapy Induced Bone Marrow Aplasia, Neutropenic Enterocolitis
Start: 2014-05-31End: 2016-12-31Target: 16Updated: 2015-06-10

Phase 2

Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
CompletedNCT00584766
University of OklahomaMetastatic Breast Cancer
Start: 1987-10-31End: 2002-05-31Updated: 2015-05-29
High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
CompletedNCT01182415
Massachusetts General HospitalCNS Lymphoma, Non-Hodgkin's Lymphoma
Start: 2010-06-30End: 2016-12-31Updated: 2023-04-06

Unknown Phase

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
CompletedNCT00303810
Universitätsklinikum Hamburg-EppendorfBrain and Central Nervous System Tumors
Start: 2001-01-31Updated: 2014-01-28